Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2021

 

Upgrades

  • Loop Capital upgraded the previous rating for Albemarle Corp ALB from Hold to Buy. In the fourth quarter, Albemarle showed an EPS of $1.17, compared to $1.73 from the year-ago quarter. At the moment, the stock has a 52-week-high of $188.35 and a 52-week-low of $48.89. Albemarle closed at $157.34 at the end of the last trading period.
  • According to Barclays, the prior rating for ManpowerGroup Inc MAN was changed from Underweight to Overweight. ManpowerGroup earned $1.48 in the fourth quarter, compared to $2.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of $99.36 and a 52-week-low of $49.57. ManpowerGroup closed at $94.41 at the end of the last trading period.
  • For Life Storage Inc LSI, Evercore ISI Group upgraded the previous rating of In-Line to Outperform. Life Storage earned $1.07 in the fourth quarter, compared to $0.96 in the year-ago quarter. The stock has a 52-week-high of $125.76 and a 52-week-low of $67.31. At the end of the last trading period, Life Storage closed at $83.93.
  • Compass Point upgraded the previous rating for RLJ Lodging Trust RLJ from Neutral to Buy. In the fourth quarter, RLJ Lodging showed an EPS of $0.57, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.17 and a 52-week-low of $3.88. RLJ Lodging closed at $15.74 at the end of the last trading period.
  • According to Compass Point, the prior rating for Park Hotels & Resorts Inc PK was changed from Neutral to Buy. In the fourth quarter, Park Hotels & Resorts showed an EPS of $0.53, compared to $0.72 from the year-ago quarter. The stock has a 52-week-high of $23.11 and a 52-week-low of $3.99. At the end of the last trading period, Park Hotels & Resorts closed at $21.75.
  • For SailPoint Technologies Holdings Inc SAIL, Needham upgraded the previous rating of Hold to Buy. SailPoint Technologies earned $0.10 in the fourth quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $64.19 and a 52-week-low of $11.61. SailPoint Technologies closed at $56.40 at the end of the last trading period.
  • Morgan Stanley upgraded the previous rating for Spirit AeroSystems Holdings Inc SPR from Equal-Weight to Overweight. For the fourth quarter, Spirit AeroSystems Hldgs had an EPS of $1.31, compared to year-ago quarter EPS of $0.79. The current stock performance of Spirit AeroSystems Hldgs shows a 52-week-high of $61.27 and a 52-week-low of $13.69. Moreover, at the end of the last trading period, the closing price was at $42.87.
  • For Yandex NV YNDX, Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. For the fourth quarter, Yandex had an EPS of $0.23, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $74.32 and a 52-week-low of $27.93. At the end of the last trading period, Yandex closed at $63.98.
  • Wells Fargo upgraded the previous rating for Bain Capital Specialty Finance Inc BCSF from Underweight to Equal-Weight. Bain Capital Specialty earned $0.34 in the fourth quarter, compared to $0.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $19.76 and a 52-week-low of $7.11. Bain Capital Specialty closed at $14.05 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Plug Power Inc PLUG was changed from Neutral to Overweight. Plug Power earned $0.05 in the fourth quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Plug Power shows a 52-week-high of $75.49 and a 52-week-low of $2.53. Moreover, at the end of the last trading period, the closing price was at $48.38.

See all analyst ratings upgrades.

 

Downgrades

  • According to Barclays, the prior rating for Kodiak Sciences Inc KOD was changed from Equal-Weight to Underweight. In the fourth quarter, Kodiak Sciences showed an EPS of $0.97, compared to $0.40 from the year-ago quarter. The stock has a 52-week-high of $171.21 and a 52-week-low of $35.49. At the end of the last trading period, Kodiak Sciences closed at $129.01.
  • Barclays downgraded the previous rating for Editas Medicine Inc EDIT from Overweight to Equal-Weight. In the fourth quarter, Editas Medicine showed an EPS of $1.00, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $99.95 and a 52-week-low of $14.01. Editas Medicine closed at $43.86 at the end of the last trading period.
  • Barclays downgraded the previous rating for Beam Therapeutics Inc BEAM from Overweight to Equal-Weight. For the third quarter, Beam Therapeutics had an EPS of $0.69, compared to year-ago quarter EPS of $3.31. The stock has a 52-week-high of $126.90 and a 52-week-low of $13.00. At the end of the last trading period, Beam Therapeutics closed at $89.13.
  • Deutsche Bank downgraded the previous rating for ams AG AMSSY from Buy to Hold. At the moment, the stock has a 52-week-high of $14.00 and a 52-week-low of $4.50. ams closed at $11.65 at the end of the last trading period.
  • According to Bernstein, the prior rating for Pioneer Natural Resources Co PXD was changed from Outperform to Market Perform. In the fourth quarter, Pioneer Natural Resources showed an EPS of $1.07, compared to $2.36 from the year-ago quarter. The stock has a 52-week-high of $153.21 and a 52-week-low of $48.62. At the end of the last trading period, Pioneer Natural Resources closed at $148.57.
  • According to HC Wainwright & Co., the prior rating for ZIOPHARM Oncology Inc ZIOP was changed from Buy to Neutral. For the fourth quarter, ZIOPHARM Oncology had an EPS of $0.11, compared to year-ago quarter EPS of $0.09. The current stock performance of ZIOPHARM Oncology shows a 52-week-high of $5.95 and a 52-week-low of $1.79. Moreover, at the end of the last trading period, the closing price was at $5.33.
  • According to Bernstein, the prior rating for Apache Corp APA was changed from Outperform to Market Perform. For the fourth quarter, Apache had an EPS of $0.05, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $26.96 and a 52-week-low of $3.80. Apache closed at $19.73 at the end of the last trading period.
  • For WSFS Financial Corp WSFS, Piper Sandler downgraded the previous rating of Overweight to Neutral. In the fourth quarter, WSFS Financial showed an EPS of $1.16, compared to $0.96 from the year-ago quarter. The current stock performance of WSFS Financial shows a 52-week-high of $55.08 and a 52-week-low of $17.84. Moreover, at the end of the last trading period, the closing price was at $53.14.
  • Wells Fargo downgraded the previous rating for TC Pipelines LP TCP from Overweight to Equal-Weight. TC Pipelines earned $1.01 in the fourth quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $41.20 and a 52-week-low of $18.00. At the end of the last trading period, TC Pipelines closed at $29.26.
  • According to Morgan Stanley, the prior rating for TechnipFMC PLC FTI was changed from Overweight to Equal-Weight. TechnipFMC earned $0.05 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of TechnipFMC shows a 52-week-high of $16.17 and a 52-week-low of $4.49. Moreover, at the end of the last trading period, the closing price was at $8.21.
  • According to RBC Capital, the prior rating for Pactiv Evergreen Inc PTVE was changed from Outperform to Sector Perform. Pactiv Evergreen earned $0.10 in the fourth quarter. At the moment, the stock has a 52-week-high of $19.61 and a 52-week-low of $10.40. Pactiv Evergreen closed at $13.98 at the end of the last trading period.
  • JP Morgan downgraded the previous rating for Agios Pharmaceuticals Inc AGIO from Overweight to Neutral. Agios Pharmaceuticals earned $1.41 in the fourth quarter, compared to $1.60 in the year-ago quarter. The current stock performance of Agios Pharmaceuticals shows a 52-week-high of $58.93 and a 52-week-low of $27.77. Moreover, at the end of the last trading period, the closing price was at $47.44.

See all analyst ratings downgrades.

 

Initiations

  • With an Overweight rating, Morgan Stanley initiated coverage on Sana Biotechnology Inc SANA. The price target seems to have been set at $40.00 for Sana Biotechnology. The current stock performance of Sana Biotechnology shows a 52-week-high of $44.60 and a 52-week-low of $29.99. Moreover, at the end of the last trading period, the closing price was at $30.74.
  • Morgan Stanley initiated coverage on Boston Beer Co Inc SAM with an Overweight rating. The price target for Boston Beer Co is set to $1400.00. For the fourth quarter, Boston Beer Co had an EPS of $2.64, compared to year-ago quarter EPS of $1.24. The current stock performance of Boston Beer Co shows a 52-week-high of $1236.57 and a 52-week-low of $290.02. Moreover, at the end of the last trading period, the closing price was at $1029.82.
  • Morgan Stanley initiated coverage on TELUS International (Cda) Inc TIXT with a Equal-Weight rating. The price target for TELUS International is set to $31.00. In the fourth quarter, TELUS International showed an EPS of $0.09, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $33.60 and a 52-week-low of $28.00. At the end of the last trading period, TELUS International closed at $29.12.
  • With a Buy rating, Stifel initiated coverage on Codexis Inc CDXS. The price target seems to have been set at $30.00 for Codexis. Codexis earned $0.06 in the fourth quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Codexis shows a 52-week-high of $29.56 and a 52-week-low of $8.43. Moreover, at the end of the last trading period, the closing price was at $22.11.
  • Credit Suisse initiated coverage on TELUS International (Cda) Inc TIXT with a Neutral rating. The price target for TELUS International is set to $33.00. TELUS International earned $0.09 in the fourth quarter, compared to $0.14 in the year-ago quarter. The stock has a 52-week-high of $33.60 and a 52-week-low of $28.00. At the end of the last trading period, TELUS International closed at $29.12.
  • Berenberg initiated coverage on Repare Therapeutics Inc RPTX with a Buy rating. The price target for Repare Therapeutics is set to $51.00. In the third quarter, Repare Therapeutics showed an EPS of $0.37, compared to $5.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $46.44 and a 52-week-low of $21.45. Repare Therapeutics closed at $32.90 at the end of the last trading period.
  • RBC Capital initiated coverage on Atotech Ltd ATC with an Outperform rating. The price target for Atotech is set to $23.00. At the moment, the stock has a 52-week-high of $20.83 and a 52-week-low of $17.00. Atotech closed at $20.18 at the end of the last trading period.
  • With a Neutral rating, Credit Suisse initiated coverage on TELUS Corp TU. The price target seems to have been set at $33.00 for TELUS. For the fourth quarter, TELUS had an EPS of $0.17, compared to year-ago quarter EPS of $0.52. The current stock performance of TELUS shows a 52-week-high of $38.66 and a 52-week-low of $13.54. Moreover, at the end of the last trading period, the closing price was at $20.04.
  • With an Outperform rating, Credit Suisse initiated coverage on Atotech Ltd ATC. The price target seems to have been set at $23.00 for Atotech. At the moment, the stock has a 52-week-high of $20.83 and a 52-week-low of $17.00. Atotech closed at $20.18 at the end of the last trading period.
  • Credit Suisse initiated coverage on Opendoor Technologies Inc OPEN with an Outperform rating. The price target for Opendoor Technologies is set to $37.00. At the moment, the stock has a 52-week-high of $39.24 and a 52-week-low of $21.41. Opendoor Technologies closed at $28.02 at the end of the last trading period.
  • SVB Leerink initiated coverage on Landos Biopharma Inc LABP with an Outperform rating. The price target for Landos Biopharma is set to $20.00. At the moment, the stock has a 52-week-high of $15.35 and a 52-week-low of $10.77. Landos Biopharma closed at $13.48 at the end of the last trading period.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on F-star Therapeutics Inc FSTX. The price target seems to have been set at $35.00 for F-star Therapeutics. The current stock performance of F-star Therapeutics shows a 52-week-high of $12.20 and a 52-week-low of $6.61. Moreover, at the end of the last trading period, the closing price was at $8.27.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on Angion Biomedica Corp ANGN. The price target seems to have been set at $100.00 for Angion Biomedica. The stock has a 52-week-high of $26.30 and a 52-week-low of $16.00. At the end of the last trading period, Angion Biomedica closed at $17.34.
  • Needham initiated coverage on DZS Inc DZSI with a Buy rating. The price target for DZS is set to $23.00. The current stock performance of DZS shows a 52-week-high of $18.90 and a 52-week-low of $2.90. Moreover, at the end of the last trading period, the closing price was at $16.64.
  • With a Neutral rating, Goldman Sachs initiated coverage on Sana Biotechnology Inc SANA. The price target seems to have been set at $40.00 for Sana Biotechnology. The current stock performance of Sana Biotechnology shows a 52-week-high of $44.60 and a 52-week-low of $29.99. Moreover, at the end of the last trading period, the closing price was at $30.74.
  • With a Buy rating, Jefferies initiated coverage on Five9 Inc FIVN. The price target seems to have been set at $220.00 for Five9. In the fourth quarter, Five9 showed an EPS of $0.34, compared to $0.27 from the year-ago quarter. The current stock performance of Five9 shows a 52-week-high of $194.03 and a 52-week-low of $52.51. Moreover, at the end of the last trading period, the closing price was at $185.24.
  • Piper Sandler initiated coverage on Sensei Biotherapeutics Inc SNSE with an Overweight rating. The price target for Sensei Biotherapeutics is set to $25.00. At the moment, the stock has a 52-week-high of $26.50 and a 52-week-low of $15.45. Sensei Biotherapeutics closed at $16.50 at the end of the last trading period.
  • Goldman Sachs initiated coverage on ON24 Inc ONTF with a Buy rating. The price target for ON24 is set to $88.00. The stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. At the end of the last trading period, ON24 closed at $56.31.
  • With a Buy rating, Needham initiated coverage on ON24 Inc ONTF. The price target seems to have been set at $70.00 for ON24. At the moment, the stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. ON24 closed at $56.31 at the end of the last trading period.
  • KeyBanc initiated coverage on ON24 Inc ONTF with an Overweight rating. The price target for ON24 is set to $70.00. The stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. At the end of the last trading period, ON24 closed at $56.31.
  • With an Overweight rating, Piper Sandler initiated coverage on ON24 Inc ONTF. The price target seems to have been set at $70.00 for ON24. At the moment, the stock has a 52-week-high of $81.98 and a 52-week-low of $46.37. ON24 closed at $56.31 at the end of the last trading period.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!